Is asthma research in dead end?

Experimental and Toxicologic Pathology

Volumn 57, Issue SUPPL. 2, 2006, Pages 45-47

  Amon, Annette ^a   Pahl, Andreas ^a   Szelenyi, Istvan ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Asthma; Chemokines; Cytokines; Glucocorticoid; Multiple mediator; Signaling

Indexed keywords

GLUCOCORTICOID; HISTAMINE H1 RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; PHOSPHODIESTERASE IV;

ARTICLE; ASTHMA; DRUG SCREENING; MEDICAL RESEARCH; PREVALENCE;

EID: 33646808313     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2006.02.006     Document Type: Article

References (5)

1. Burney P.G., Chinn S., and Rona R.J. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86. BMJ 300 (1990) 1306-1310
2. Busse W.W., Middleton E., Storms W., Dockhorn R.J., Chu T.J., Grossman J., et al. Am J Respir Crit Care Med. 153 (1996) 122-127
3. Dirksen A., Engel T., Frolund L., Heinig J.H., Svendsen U.G., and Weeke B. Effect of a non-sedative antihistaminic (loratadine) in moderate asthma. A double-blind controlled clinical crossover-trial. Allergy 44 (1989) 566-571
4. English J.M., and Cobb M.H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci (2002) 40-45
5. Honda K., Marquillies P., Capron M., and Dombrowicz D. Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model. J Allergy Clin Immunol 113 (2004) 882-888